Plus Therapeutics regains compliance with Nasdaq

* Plus Therapeutics (PSTV [https://seekingalpha.com/symbol/PSTV]) said that [https://seekingalpha.com/pr/20480501-plus-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement] it has received a Nasdaq notice that its common stock has again met the exchange’s minimum bid‑price requirement of at least $1.00 per share.
* Nasdaq determined that, for the 10 consecutive business days from April 6, 2026 to April 17, 2026, the closing bid price of the company's common stock was at or above $1.00 per share.
* PSTV (PSTV [https://seekingalpha.com/symbol/PSTV]) stock price moved about 2.9% higher on Tuesday in pre-market trade.

MORE ON PLUS THERAPEUTICS

* Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering - Slideshow [https://seekingalpha.com/article/4864605-plus-therapeutics-inc-pstv-discusses-business-update-reyobiq-clinical-program-progress-and]
* Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript [https://seekingalpha.com/article/4861897-plus-therapeutics-inc-pstv-discusses-business-update-reyobiq-clinical-program-progress-and]
* Plus Therapeutics announces 1-for-25 reverse stock split [https://seekingalpha.com/news/4570608-plus-therapeutics-announces-1-for-25-reverse-stock-split]
* Plus Therapeutics GAAP EPS of -$0.29 beats by $0.01, revenue of $5.21M beats by $0.14M [https://seekingalpha.com/news/4564033-plus-therapeutics-gaap-eps-of-0_29-beats-by-0_01-revenue-of-5_21m-beats-by-0_14m]
* Seeking Alpha’s Quant Rating on Plus Therapeutics [https://seekingalpha.com/symbol/PSTV/ratings/quant-ratings]